CVE Rallies 13.7% in the Past Month. Can the Stock Keep Climbing?

Cenovus Energy Inc. CVE has gained 13.7% in the past month, extending a sharp 2026 advance. The rally now puts more weight on whether operating momentum can keep supporting the shares.

Production growth, a refining rebound and positive earnings estimate revisions strengthen the case. Valuation is less forgiving, however, with the stock trading near the top of its five-year sales-multiple range.

CVE's Oil Sands Growth Adds Fundamental Support

Second-quarter upstream production reached 970.4 thousand barrels of oil equivalent per day, up 27% year over year. Oil Sands production rose to 786.4 thousand barrels of oil equivalent per day from 579.8 thousand a year earlier, helped by additional MEG volumes, Christina Lake redevelopment, Narrows Lake and Foster Creek gains.

The growth runway remains visible. Cenovus raised the midpoint of its 2026 upstream production guidance to a range of 970 thousand barrels of oil equivalent per day to 1.01 million barrels of oil equivalent per day and continues to target nearly 1.1 million barrels of oil equivalent per day by the end of 2028. Sunrise and West White Rose provide additional project support.

CVE's Refining Rebound Broadens Earnings Strength

Downstream operating margin improved to C$953 million from a C$71 million loss a year earlier. U.S. Refining generated C$771 million of operating margin against a C$178 million loss, while downstream crude utilization reached 95%.

That recovery shows the value of Cenovus' integrated model when refining conditions are favorable. Suncor Energy Inc. SU, another large Canadian integrated producer, reported second-quarter 2026 refinery throughput of 470.6 thousand barrels per day and 92% utilization. Imperial Oil Limited IMO also spans upstream and downstream operations, though planned turnaround activity held its second-quarter refinery utilization to 76%.

CVE's Estimate Revisions Add Another Positive Signal

The Zacks Consensus Estimate for 2026 earnings has increased 6% over the past four weeks and 6.3% over the past 12 weeks. Rising estimates are supportive because earnings revisions are central to Zacks' short-term rating methodology.

The earnings path is not uniformly higher. The consensus estimate calls for earnings of $3.20 per share in 2026 and $2.76 in 2027, indicating moderation after this year's expected increase. That makes continued operating execution important if the stock is to extend its recent run.

Image Source: Zacks Investment Research

Cenovus Valuation Leaves Less Room for Error

Cenovus trades at 1.6X forward 12-month sales, matching the high end of its five-year range and standing well above the five-year median of 0.8X. The multiple is below the Zacks sub-industry's 1.8X but above the broader energy sector's 1.4X.

Image Source: Zacks Investment Research

That valuation does not eliminate upside, but it raises the bar. Commodity-price sensitivity, heavy-oil differentials and downstream margin volatility remain relevant, while net debt of C$5.4 billion at June 30 was still above the company's C$4.0 billion long-term target.

CVE's Ratings Favor Quality Over a Chase

Cenovus has several operating supports behind the rally, but the stock's fuller valuation and expected 2027 earnings moderation argue against treating recent momentum as a one-way signal. The setup looks balanced rather than decisively bullish.

CVE currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

It also has a Value Score of A, Growth Score of A, Momentum Score of B and VGM Score of A. Those Style Scores point to favorable value, growth and momentum characteristics, but they are designed to complement the Zacks Rank rather than override it. For now, the combination favors a measured stance while investors watch whether execution keeps pace with the higher valuation.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research